BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
41156 results:

  • 1. Malignant melanotic schwannoma of the cervical spinal cord: a case report.
    Chen S; Wei Y
    BMC Neurol; 2024 May; 24(1):181. PubMed ID: 38816740
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk factors, impact and treatment of postoperative lymphatic leakage in children with abdominal neuroblastoma operated on by laparotomy.
    Feng J; Mou J; Yang S; Ren Q; Chang S; Yang W; Cheng H; Chang X; Zhu Z; Han J; Qin H; Wang H; Ni X
    BMC Surg; 2024 May; 24(1):168. PubMed ID: 38811926
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ethnic disparities in complete and partial molar pregnancy incidence: a retrospective analysis of arab and jewish women in single medical center.
    Aiob A; Gumin D; Zilberfarb I; Naskovica K; Sgayer I; Mikhail SM; Sharon A; Lowenstein L
    BMC Public Health; 2024 May; 24(1):1440. PubMed ID: 38811887
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
    Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
    Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
    Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
    Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma grading.
    Cadrien C; Sharma S; Lazen P; Licandro R; Furtner J; Lipka A; Niess E; Hingerl L; Motyka S; Gruber S; Strasser B; Kiesel B; Mischkulnig M; Preusser M; Roetzer-Pejrimovsky T; Wöhrer A; Weber M; Dorfer C; Trattnig S; Rössler K; Bogner W; Widhalm G; Hangel G
    Cancer Imaging; 2024 May; 24(1):67. PubMed ID: 38802883
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of Cannabis sativa L. extracts, phytocannabinoids and their acetylated derivates on the SHSY-5Y neuroblastoma cells' viability and caspases 3/7 activation.
    Tapia-Tapia E; Aránguiz P; Diaz R; Espinoza L; Weinstein-Oppenheimer CR; Cuellar M
    Biol Res; 2024 May; 57(1):33. PubMed ID: 38802872
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
    Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
    BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity.
    Püsküllüoğlu M; Grela-Wojewoda A; Ambicka A; Pacholczak-Madej R; Pietruszka A; Mucha-Małecka A; Rudzińska A; Ziobro M; Ryś J; Mituś JW
    Front Endocrinol (Lausanne); 2024; 15():1217495. PubMed ID: 38800480
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Joinpoint regression analysis of recent trends in desmoplastic malignant melanoma incidence and mortality: 15-year multicentre retrospective study.
    Yu H; Zhu L; Zhang J; Zheng S; Ming WK; Ip CC; Jiang Y; Chen W; Wu S; Lyu J; Deng L
    Arch Dermatol Res; 2024 May; 316(6):273. PubMed ID: 38796649
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on
    Gao J; Zhou J; Liu C; Pan Y; Lin X; Zhang Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):272. PubMed ID: 38795250
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fluorescein-guided surgery in high-grade gliomas: focusing on the eloquent and deep-seated areas.
    Xiao Y; Li M; Wang X; Tan J; Qin C; Liu Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):274. PubMed ID: 38795238
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Early diagnosis of melanoma: a randomized trial assessing the impact of the transmission of photographs taken with a smartphone from the general practitioner to the dermatologist on the time to dermatological consultation.
    Bouton C; Schmeltz H; Lévèque C; Gaultier A; Quereux G; Dreno B; Nguyen JM; Rat C
    BMC Health Serv Res; 2024 May; 24(1):660. PubMed ID: 38783296
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of two region-of-interest placement methods for histogram analysis of apparent diffusion coefficient maps for glioma grading.
    Hieu ND; Hung ND; Hung ND; Hien MM; Anh DV; Dung LT
    Clin Ter; 2024; 175(3):128-136. PubMed ID: 38767069
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
    Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nodular image in the appendix observed on ultrasound: endometriosis or neuroendocrine neoplasia?
    Haddad RF; de Azevedo BC; de Mattos LA; Podgaec S
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765516
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
    Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
    Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.
    Rosas-Alonso R; Colmenarejo-Fernández J; Pernía O; Burdiel M; Rodríguez-Antolín C; Losantos-García I; Rubio T; Moreno-Velasco R; Esteban-Rodríguez I; Martínez-Marín V; Yubero P; Costa-Fraga N; Díaz-Lagares A; López-López R; Díaz-Martin E; García JF; Sánchez CV; Gandía-González ML; Moreno-Bueno G; de Castro J; de Cáceres II
    Sci Rep; 2024 May; 14(1):11398. PubMed ID: 38762534
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2058.